Document:

EX-10.17

 Exhibit 10.17 
 13 November 2007 
 Bruce Powell Esq. 
 Broadhatch House 
 Bentley 
 Farnham GU10 5JJ 
 Surrey 
 Renewal of Appointment as a Non-Executive director of DICOM Group plc 
 Dear Bruce

 Your appointment will be renewed from the Annual General Meeting of DICOM Group plc (‘the Company’), to be held on 13 November
2007. We are writing to set out the terms of your appointment. 
 Appointment 
 Your appointment will continue until the Annual General Meeting of the Company held following the financial year ending 30 June 2008, unless otherwise terminated earlier by and at the discretion of
either party upon six month’s written notice. Continuation of your contract of appointment is contingent on satisfactory performance and re-election at forthcoming AGMs. 
 Time commitment 
 Overall we anticipate a time commitment of 1 - 2 days per month. This will
include attendance at approx. 8 Board meetings, either physically or by conference call, and the AGM. In addition, you will be expected to devote appropriate preparation time ahead of each meeting. 

By accepting this appointment, you have confirmed that you are able to allocate sufficient time to meet the expectations of your role. The agreement of
the Chairman should be sought before accepting additional commitments that might affect the time you are able to devote to your role as a Non-Executive Director of the Company. 

 Role 
 Non-Executive Directors have the same general legal responsibilities to the Company as any other Director. The Board as a whole is collectively responsible for promoting the success of the Company by
directing and supervising the Company’s affairs. The Board: 
  

	•	 	 provides entrepreneurial leadership of the Company within a framework of prudent and effective controls which enable risk to be assessed and managed;

  

	•	 	 sets the Company’s strategic aims, ensures that the necessary financial and human resources are in place for the Company to meet its objectives,
and reviews management performance; and 

  

	•	 	 sets the Company’s values and standards and ensures that its obligations to its shareholders and others are understood and met.

 In addition to these requirements of all Directors, the role of the Non-Executive Director has the following key elements:

  

	•	 	 Strategy: Non-Executive Directors should constructively challenge and contribute to the development of strategy; 

 

	•	 	 Performance: Non-Executive Directors should scrutinise the performance of management in meeting agreed goals and objectives and monitor the reporting
of performance; 

  

	•	 	 Risk: Non-Executive Directors should satisfy themselves that financial information is accurate and that financial controls and systems of risk
management are robust and defensible; and 

  

	•	 	 People: Non-Executive Directors are responsible for determining appropriate levels of remuneration of executive directors and have a prime role in
appointing, and where necessary removing, senior management and in succession planning. 

 Fees 

You will be paid a fee of £35,000 gross per annum which will be paid monthly in arrears, subject to an annual review by the Board. The Company will
reimburse you for all reasonable and properly documented expenses you incur in performing the duties of your office. It is agreed that reasonable expense include economy class air travel on flights below six hours. On long haul flights over six
hours business class travel is allowed. 
 Outside interests 
 It is accepted and acknowledged that you have business interests other than those of the Company and have declared any conflicts that are apparent at present. In the event that you become aware of any
potential conflicts of interest, these should be disclosed to the Chairman and Company Secretary as soon as apparent. 

 Confidentiality 
 All information acquired during your appointment is confidential to the Company and should not be released, either during your appointment or following termination (by whatever means), to third parties
without prior clearance from the chairman. Your attention is also drawn to the requirements under both legislation and regulation as to the disclosure of price sensitive information. Consequently you should avoid making any statements that might
risk a breach of these requirements without prior clearance from the Chairman or Company Secretary. 
 Review process 

The performance of individual directors and the whole Board and its committees is evaluated annually. If, in the interim, there are any matters which
cause you concern about your role you should discuss them with the Chairman as soon as is appropriate. 
 Insurance 

The Company has directors’ and officers’ liability insurance and it is intended to maintain such cover for the full term of your appointment.
The current indemnity limit is approximately £8 million. 
 Independent professional advice 

Occasions may arise when you consider that you need professional advice in the furtherance of your duties as a director. Circumstances may occur when it
will be appropriate for you to seek advice from independent advisors at the Company’s expense. The Company will reimburse the full cost of expenditure incurred. 
 Matters reserved to the Board 
 Enclosed you will find a schedule of matters reserved to the
Group Board. 
 Committees 

This letter refers to your appointment as a Non-Executive Director of the Company. You will also serve as Chairman of the Audit Committee and serve as
member on the Nomination Committee, as defined within the committee’s terms of reference. It is also proposed that you continue to serve as the Senior Non-Executive Director of the Board. The above-mentioned fee covers these additional
responsibilities. 

 Please confirm your acceptance of this appointment by signing the duplicate original of this letter and
returning it to the Company Secretary. 
 Yours sincerely, 
 DICOM Group plc 
  

					
	/s/ Greg Lock	 		 	/s/ Stefan Gaiser
	Greg Lock	 		 	Stefan Gaiser
	Chairman	 		 	Company Secretary

 I accept the terms of this letter 
 /s/ Bruce Powell 
 Bruce Powell 

 Enclosure 
 Matters reserved to the Group Board: 
  

	•	 	 Approval Group’s strategic plans 

  

	•	 	 Appointments to/removals from Group Board (both exec and non-exec, including Company Secretary) 

 

	•	 	 Appointment/removal of Group Chief Executive 

  

	•	 	 Group Organisation Chart (incl. Management and Business Development Teams) 

 

	•	 	 Recommendations of Audit Committee 

  

	•	 	 Recommendations of Remuneration Committee 

  

	•	 	 Recommendations of Nomination Committee 

  

	•	 	 Appointment/removal of executives with OTE remuneration in excess of EUR 150k pa 

 

	•	 	 Appointment/removal of Auditors/Nominated Advisers 

  

	•	 	 Set up new subsidiary 

  

	•	 	 Terms of acquisition/disposal or part disposal of subsidiaries, business or assets 

 

	•	 	 Capital expenditure in excess EUR 250k (outside of budget) 

 

	•	 	 Approval of Group Budget and mid term operating plans 

 

	•	 	 Approval of Group Accounts 

  

	•	 	 Approval of Group Accounting Policies 

  

	•	 	 Approval of Group Announcements to Stock Exchange 

  

	•	 	 Approval of Model Share Dealing Code 

  

	•	 	 Set up of Financing Facilities in excess EUR 600k 

  

	•	 	 Pledge of Group assets as security 

  

	•	 	 DICOM Group plc guarantees to financiers/suppliers 

  

	•	 	 Rules for dealing on Foreign Exchange markets 

  

	•	 	 Proposed departures from rules for dealing on Foreign Exchange markets (above) 

 

	•	 	 Establishment of Group Share Option schemes and grants thereunder 

 

	•	 	 Establishment of Group Pension Scheme 

  

	•	 	 Approval of all transactions with “connected persons” 

 

	•	 	 Issue of shares in Group companies 

  

	•	 	 Approval of property/equipment leases in excess EUR 250k pa (outside of budget) 

 

	•	 	 Initiate and respond to major litigation 

  

	•	 	 Risk and internal control: overall approach to assessing risk and control systemsEX-10.18

 Exhibit 10.18 

 
 

 
  
  

 

							
		 		 		 	 Kofax Plc
 16245 Laguna Canyon
Road
 Irvine, CA 92618-3603

USA
 TEL: 949 727-1733

FAX: 949 727-3144

www.kofax.com

 Joe A. Rose 
 3924 Southwestern Blvd. 
 Dallas, Texas 75225 

17 February 2009 
 With effect from
1 April 2009, the board of Kofax plc (the “Company”) has appointed you as non-executive director. I am writing to set out the terms of your appointment. It is agreed that this is a contract for services and is not a contract of
employment. 
 Appointment 

Your appointment will be for an initial term of three years commencing on 1 April 2009, unless otherwise terminated earlier by and at the discretion
of either party upon six months’ written notice. Continuation of your contract of appointment is contingent on satisfactory performance and re-election at forthcoming AG Ms. Nonexecutive directors are typically expected to serve two
three-year terms, although the board may invite you to serve an additional period. 
 Time Commitment 

Overall we anticipate a time commitment of one to two days per month after the induction phase. This will include attendance at approximately eight board
meetings per annum (either physically or by conference call) and the AGM. In addition, you will be expected to devote appropriate preparation time ahead of each meeting. 
 By accepting this appointment, you have confirmed that you are able to allocate sufficient time to meet the expectations of your role. The agreement of the chairman should be sought before accepting
additional commitments that might impact on the time you are able to devote to your role as a non-executive director of the Company. 
 Role

 Non-executive directors have the same general legal responsibilities to the Company as any other director. The board as a whole is
collectively responsible for the success of the Company. The board: 
  

	 	•	 	 provides entrepreneurial leadership of the Company within a framework of prudent and effective controls which enable risk to be assessed and managed;

  

	 	•	 	 sets the Company’s strategic aims, ensures that the necessary financial and human resources are in place for the Company to meet its objectives,
and reviews management performance; and 

  

	 	•	 	 sets the Company’s values and standards and ensures that its obligations to its shareholders and others are understood and met.

 All directors must take decisions objectively in the interests of the Company. 

 
 

 

 In addition to these requirements of all directors, the role of the non-executive director has the
following key elements: 
  

	 	•	 	 Strategy. Non-executive directors should constructively challenge and help develop proposals on strategy; 

 

	 	•	 	 Performance. Non-executive directors should scrutinise the performance of management in meeting agreed goals and objectives and monitor the
reporting of performance; 

  

	 	•	 	 Risk. Non-executive directors should satisfy themselves on the integrity of financial information and that financial controls and systems of
risk management are robust and defensible; and 

  

	 	•	 	 People. Non-executive directors are responsible for determining appropriate levels of remuneration of executive directors and have a prime role
in appointing, and where necessary removing, executive directors and in succession planning. 

 Fees 

You will be paid a fee of US$80,000 gross per annum which will be paid monthly in arrears and which will be subject to an annual review by the board. The
Company will reimburse you for all reasonable and properly documented expenses you incur in performing the duties of your office. It is agreed that reasonable expenses include business class air travel. 

Outside interests 
 It is accepted and
acknowledged that you have business interests other than those of the Company and have declared any conflicts that are apparent at present. In the event that you become aware of any potential conflicts of interest, these should be disclosed to the
chairman and company secretary as soon as apparent. 
 Confidentiality 
 All information acquired during your appointment is confidential to the Company and should not be released, either during your appointment or following termination (by whatever means), to third parties
without prior clearance from the chairman. 
 Your attention is also drawn to the requirements under both legislation and regulation as to the
disclosure of price sensitive information. Consequently you should avoid making any statements that might risk a breach of these requirements without prior clearance from the chairman or company secretary. 

Induction 
 The Company will promptly
provide a comprehensive, formal and tailored induction. 
 Review process 
 The performance of individual directors and the whole board and its committees is evaluated annually. If, in the interim, there any matters which cause you concern about your role you should discuss them
with the chairman as soon as is appropriate. 
 Insurance 
 The Company has directors’ and officers’ liability insurance and it is intended to maintain such cover for the full term of your appointment. 

 
 

 

 Independent professional advice 
 Occasions may arise when you consider that you need professional advice in the furtherance of your duties as a director. Circumstances may occur when it will be appropriate for you to seek advice from
independent advisers at the Company’s expense. The Company will reimburse the full cost of expenditure incurred in accordance with its policy. 
 Committees 
 This letter refers to your appointment as a non-executive director of the
Company. You will also serve as member of the Nomination and Remuneration Committees, as defined within the terms of reference of those committees. The above-mentioned fee also covers these additional responsibilities. 

Please confirm your acceptance of this appointment by signing the duplicate original of this letter and returning it to the company secretary.

  

	
	Yours sincerely,
	
	/s/ Greg Lock
	
	Greg Lock
	Chairman
	Kofax plc

 I accept the terms of this letter. 
  

					
	 /s/ Joe A. Rose
	 		 	 02/18/09

	Joe A. Rose	 		 	Date

  
 

 

 ANNEX 
 Matters Reserved to the Board of Directors 
  

	A.	MANAGEMENT STRUCTURE AND APPOINTMENTS 

  

	 	•	 	 Appointment/Removal of Chief Executive Officer (CEO) 

  

	 	•	 	 Other Appointment to/Removals from Company Board (both executive and non-executive, including company secretary) 

 

	 	•	 	 Determination of Non-executive Remuneration 

  

	 	•	 	 Appointment/Removal of Members of the Executive Management Team and other direct reports to the CEO 

 

	 	•	 	 Adoption and Amendment of Standing Committee Terms of Reference 

 

	 	•	 	 Appointment of Audit Committee Chair and Members 

  

	 	•	 	 Appointment of Remuneration Committee Chair and Members 

 

	 	•	 	 Appointment of Nomination Committee Chair and Members 

 

	 	•	 	 Appointment/Removal of Auditors and other Advisers to the Board 

 

	 	•	 	 Allocation of Executive Management Team Responsibilities 

 

	 	•	 	 Company Board and Executive Management Team Succession Planning, Training and Development (based on recommendations of Nomination Committee)

  

	 	•	 	 Agreement with the Remuneration Committee on Policy for Remuneration of Board Members and Executive Management Team 

 

	 	•	 	 Discretionary Delegation of Powers to ad hoc Committees 

 

	 	•	 	 Appointment of ad hoc Committee Chair and Members and Terms of Reference 

 

	 	•	 	 Determination of Matters Referred to Company Board by Committees 

 

	B.	STRATEGY AND POLICY 

  

	 	•	 	 Annual Approval of Company Strategic Plan and Annual Operating Budget 

 

	 	•	 	 Approval of Mid-term Changes to Operating Budget 

  

	 	•	 	 Purchase/Relinquishment of D&O Liability Insurance Coverage 

 

	 	•	 	 Approval of and Amendment to Model Share Dealing Code 

 

	 	•	 	 Annual Review of Risk and Internal Control: Overall Approach to Assessing Risk and Control Systems (Short-term management may be delegated to Audit
Committee) 

  

	C.	RECURRENT TRANSACTIONS 

  

	 	•	 	 Approval of Accounts 

  

	 	•	 	 Approval of Change to Accounting Policies 

  

	 	•	 	 Approval of Announcements to Stock Exchange 

  

	 	•	 	 Establishment of Share Option Schemes and Grants under such Schemes (granting authority may be delegated to and exercised by Remuneration Committee)

  

	 	•	 	 Establishment of Pension Scheme 

  

	 	•	 	 Changes to Capital Structure and Approval of Payment of Dividends 

 

	 	•	 	 Issue or Transfer of Shares in Company or its Subsidiaries to Third Parties (i.e. other than in respect of share option schemes)

  

	 	•	 	 Convening of General Meetings 

  

	 	•	 	 Approval of Circulars to Shareholders/Ancillary Documentation 

 

	D.	AD HOC TRANSACTIONS 

  

	 	•	 	 Terms of Acquisition/Disposal or Part Disposal of Subsidiaries, Business or Assets 

 

	 	•	 	 Establishment of New Subsidiaries 

  

	 	•	 	 Approval of Borrowing/Finance Facilities of EUR 1m or more 

 
 

 

	 	•	 	 Pledge of Assets as Security for Borrowing of EUR 500k or more 

 

	 	•	 	 Approval of Guarantees to Financiers/Suppliers for Liabilities of EUR 500k or more 

 

	 	•	 	 Approval of Contracts with Term exceeding One Year and Financial Impact exceeding EUR 500k 

 

	 	•	 	 Initiate Litigation for Recovery of EUR 250k or more or Settlement of Claims against the Company of more than EUR 250k 

 

	 	•	 	 Capital Expenditure/leases in excess of EUR 250k per annum (outside of budget) 

 

	 	•	 	 Approval of all Transactions with “connected persons” 

 

	 	•	 	 Approval of Contracts other than on Arm’s Length Terms or Outside the Ordinary Course of Business

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00222-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00222-of-00352.parquet"}]]